NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Data Modernization for Federal Health Enterprise
Technology and modernized data systems are opening up new frontiers for health care clinicians, agencies and patients.
37m watch -
Leveraging Data for DHS Operational Efficiency
Officials share insights on data integration, AI and trustworthiness in immigration operations.
12m watch -
Inside the Latest Version of NIST’s Cybersecurity Framework
Stephen Quinn discussed how the Cybersecurity Framework 2.0 can enhance cybersecurity governance and prepare for the future.
9m watch -
White House's Plan for Hiring Reform Signals Tech, AI Needs
Here is what President Donald Trump's workforce hiring plan might mean for IT modernization at federal agencies.
5m read
